MedTrace Logo

Tregocel® as a Dietary Supplement in Mild Knee Osteoarthritis

NCT03636035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-09-21

No results posted yet for this study

Summary

This study is an assessment of the overall performance of participants with symptomatic mild knee OA taking Tregocel® as a dietary supplement in addition to standard of care treatment.

Conditions

  • Mild Knee Osteoarthritis

Interventions

DIETARY_SUPPLEMENT

Tregocel®

Coated tablet (oral)

Sponsors & Collaborators

  • Max Biocare Pty. Ltd.

    lead INDUSTRY

Principal Investigators

  • Krzysztof Wilczek, MD · Coramed, Wroklaw

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03636035 on ClinicalTrials.gov